Fenofibrate and kidney:Increase in serum creatinine

[DRH-sangli]

Fenofibrate has been used for the management of atherogenic dyslipidaemia for many years. Reports of fenofibrate-associated increases in serum creatinine (SCr) levels raised concerns regarding deleterious effects on renal function.

Fenofibrate may not be a nephrotoxic drug. However, a close monitoring of SCr levels is relevant especially in high-risk patients. Increases in SCr levels ≥30% can impose treatment discontinuation.

See the article—-

ncbi.nlm.nih.gov/pubmed/234...

[gangadharan_nair]

Fenofibrate can increase serum creatinine levels; renal function should be monitored periodically in patients with renal insufficiency

Sources:--

en.wikipedia.org/wiki/Fenof...

medlineplus.gov/druginfo/me...